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Insulin resistance and type 2 diabetes correlate with impaired leptin and insulin signaling. Insulin
receptor substrate-2 deficient (IRS2/) mice are an accepted model for the exploration of alter-
ations in these signaling pathways and their relationship with diabetes; however, disturbances in
hypothalamic signaling and the effect on neuropeptides controlling food intake remain unclear.
Our aim was to analyze how leptin and insulin signaling may differentially affect the expression
ofhypothalamicneuropeptides regulating food intakeandhypothalamic inflammation indiabetic
(D) and nondiabetic (ND) IRS2/mice.We analyzed the activation of leptin and insulin targets by
Western blotting and their association by immunoprecipitation, as well as the mRNA levels of
neuropeptide Y (NPY), proopiomelanocortin, and inflammatory markers by real-time PCR and
colocalization of forkhead box protein O1 (FOXO1) and NPY by double immunohistochemistry in
the hypothalamus. Serum leptin and insulin levels and hypothalamic Janus kinase 2 and signal
transducerandactivatorof transcription factor3activationwere increased inND IRS2/mice. IRS1
levels and its associationwith Januskinase2andp85andproteinkinaseBactivationwere increased
inND IRS2/. Increased FOXO1positively correlatedwithNPYmRNA levels inD IRS2/mice,with
FOXO1 showing mainly nuclear localization in D IRS2/ and cytoplasmic in ND IRS2/ mice. D
IRS2/mice exhibited higher hypothalamic inflammation markers than ND IRS2/mice. In con-
clusion, differential activation of these pathways and changes in the expression of NPY and in-
flammation may exert a protective effect against hypothalamic deregulation of appetite, sug-
gesting thatmanipulationof these targets couldbeof interest in the treatmentof insulin resistance
and type 2 diabetes. (Endocrinology 153: 0000–0000, 2012)
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The loss of expression of genes encoding insulin-sig-naling mediators provokes defects similar to those
reported in insulin resistance and type 2 diabetes (1).
Most studies have analyzed the molecular mechanisms
of insulin resistance in peripheral tissues, with few re-
ports showing the effects on hormone signaling in the
brain (2). The leptin and insulin signaling pathways are
interconnected at different levels, including insulin re-
ceptor substrates (IRS) and phosphatidylinositol 3-ki-
nase (PI3K) (3). Leptin mimics the ability of insulin to
promote glucose uptake through the activation of Janus
kinase 2 (JAK2) that phosphorylates IRS2, activating
PI3K. In addition, administration of PI3K inhibitors
blocks the ability of leptin and insulin to reduce food
intake (4), suggesting that PI3K signaling is implicated
in the central actions of both hormones.
Although insulin’s actions are primarily mediated
through IRS2, some data suggest that IRS1 is pivotal in
mediating insulin’s actions inperipheral tissueswhen IRS2
is absent (5, 6). PI3K is especially activated in insulin target
cells that express IRS (7), but it can also be activated in
response to different hormones acting through the JAK2
pathway (8), as does leptin, further reinforcing the link
between leptin and insulin signaling pathways.
Leptin and insulin regulate food intake by increasing
anorexigenic and diminishing orexigenic pathways in
the hypothalamus. Activation of insulin signaling in the
hypothalamus reduces food intake by negatively regu-
lating the forkhead box protein O1 (FOXO1), a tran-
scription factor that stimulates the expression of neu-
ropeptide Y (NPY) and inhibits the expression of
proopiomelanocortin (POMC) (9), whereas leptin-
stimulated signal transducer and activator of transcrip-
tion factor 3 (STAT3) activation in POMCneurons also
plays a key role in the maintenance of energy balance
(10). A significant proportion of IRS2-deficient mice
develop diabetes abruptly at 12–16 wk of age, whereas
others present less deterioration of glucose homeostasis
yet not leading to diabetes at this age. Increased food
intake has been reported in diabetic IRS2-deficient
(IRS2/) mice (11), as well as in mildly glucose-intol-
erant IRS2/ females (12). Food intake regulates
nucleus-cytoplasmic translocation of FOXO1 in hypo-
thalamic neurons (13); therefore, it is likely that distur-
bances in insulin signaling may be related to high levels
and nuclear localization of this transcription factor.
IRS2-deficient mice have been widely considered as an
excellent model to study the development of diabetes be-
cause they present a sudden increase in blood glucose sim-
ilar to that observed in fulminant diabetes onset in hu-
mans. The appearance of diabetes seems to be due to
insufficient -cell proliferation in conjunction with he-
patic insulin resistance (14), although the hypothalamus
may play a key role for the early onset of diabetes as it is
involved in the control of glucose homeostasis and energy
balance (15, 16). Changes in food intake and obesity in
IRS2/mice could be more closely related to central sig-
naling defects, because insulin signaling is impaired in the
hypothalamus of IRS2/ mice (17). Thus, alterations of
leptin/insulin signaling in the hypothalamus could be a
cause of the obese phenotype reported in these mice (2).
It has been reported that hypothalamus is a key target
for inflammation (18, 19), and this activation is mainly
attributed to the release of cytokines (20). During the last
decade, type 2 diabetes has been linked to a low grade of
hypothalamic inflammation. A proinflammatory cyto-
kine profile has been associated with increased insulin re-
sistance often found with aging (21). Moreover, the in-
tracerebroventricular injection of TNF- or IL blunts the
effects of anorexigenic hormones (22) and induces hypo-
thalamic inflammation, reproducing some clinical fea-
tures of this metabolic disease (23). Hence, a central in-
jectionofTNF-also causes an increase inbaselineplasma
insulin levels and insulin secretionby thepancreas, leading
to defective pancreatic islet function (24). In addition, hy-
pothalamic inflammation can impair hepatic insulin sig-
naling, a key factor involved in the appearance of type 2
diabetes (25), reinforcing again the possible role of the
hypothalamus in the onset of diabetes. Activation of the
PI3K pathway inhibits inflammatory processes induced in
animal models (26), and antiinflammatory drugs increase
protein kinase B (Akt) phosphorylation (27), whereas a
burst ofAkt activationhasbeen shown tooccur inneurons
exposed to nuclear factor B (NFB) inhibitors (28).
These findings suggest that modifications of both signal-
ing pathways not only contribute to changes in food in-
take, but also to hypothalamic inflammation associated
with insulin resistance.
The goal of this study was 2-fold. First, we have an-
alyzed the association between the activation of the lep-
tin and insulin signaling pathways and the hypotha-
lamic expression of neuropeptides that regulate food
intake in diabetic and nondiabetic IRS2-deficient mice.
Second, we have evaluated changes in hypothalamic in-
flammation parameters and their possible relationship
with these signaling pathways in both groups of IRS2-
deficient mice.
Materials and Methods
All studies were approved by the local ethics committee and
complied with the Royal Decree 1201/2005 (Boletín Oficial del
Estado, BOE no. 252) pertaining to the protection of experi-
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mental animals as well as with the European Communities
Council Directive (86/609/EEC).
Animals
Wild-type (WT) and IRS2/ mice, maintained on a similar
mixed genetic background (C57BL/6 129sv), were purchased
from The Jackson Laboratory (Bar Harbor, ME). Thirty-six
adult, 11- to 12-wk-old male mice were individually caged and
maintained on a 12-h light, 12-h dark cycle and fed standard
chow and water ad libitum. Three groups of mice were used: 12
WT mice as controls, 12 diabetic IRS2/ (D IRS2/) with
nonfasting glucose levels over 27.75 mmol/liter (determined by
the glucose oxidase method by using the Precision G glucose
meter; Abott Laboratories, North Chicago, IL), and 12 age-
matched non-diabetic mice IRS2/ (ND IRS2/) with glucose
levels under11.10mmol/liter. Food intakeandbodyweightwere
measureddaily at the samehour. Six to sevendays after the debut
of diabetes, animals were killed by decapitation at 0010 h under
nonfasting conditions. Mice from the control and ND IRS2/
groups were killed at the same time as the D IRS2/ mice. In
eight animals per group, the hypothalamus was divided in two
halves, with one hemihypothalamus being used for immunopre-
cipitation andWestern blot or bead array assay and the other for
RNA extraction. Four animals were perfused with 4% parafor-
maldehyde, and the hypothalamus was isolated for immunohis-
tochemistry. Trunk bloodwas collected in cooled tubes and cen-
trifuged at 3000 g for 10 min at 4 C. The serum was stored at
80 C until the hormone levels were measured.
Metabolic studies
Energy expenditure was measured by using an indirect open-
circuit calorimeter (Oxylet, Panlab, Barcelona, Spain). Six mice
per group were housed in individual metabolic chambers with
acclimatization for 24 h before data were registered for 3 min
every 20min for 48 h.Animals had free access to food andwater.
Locomotor activity was measured by continuous recording of
spontaneous activity by extensiometric weight transducers
placed below the cages, which allow detection of activity even
withoutdisplacement.Thenumberof rearingswasmonitoredby
means of an infrared frame beam-interruption method. Calcu-
lations were performed with the Metabolism 2.2.01 software
(Panlab).
Immunoprecipitation
The associations between targets were studied by immuno-
precipitation. The half of each hypothalamus was homogenized
on ice in500l of lysis buffer (pH7.6) containing50mMHEPES,
10 mM EDTA, 50 mM sodium pyrophosphate, 100 mMNaF, 10
mM Na3VO4, 1% Trito´n X-100, 2 mM phenylmethylsulfonyl
fluoride, 10 g/ml leupeptin, and 10 g/ml aprotinin. Protein
(500 g) was immunoprecipitated overnight at 4 C with the
corresponding antibodies and then incubated with protein A-
agarose beads (Roche, Mannheim, Germany) for 2 h at 4 C.
Immunocomplexes were washed three times with lysis buffer,
extracted for 5min at 95C in 4 SDS-PAGE sample buffer (200
mM Tris-HCl, 12% sodium dodecyl sulfate, 4 mM EDTA, 8%
2-mercaptoethanol, 20% glycerol) and analyzed by Western
blotting.
Western blotting
The lysates were incubated overnight at80C
and then clarified by centrifugation at 12,000 g
for5minat4C.The supernatantswere transferred
to fresh tubes and stored at 80 C until assayed.
Total protein concentrationwasdeterminedby the
method of Bradford (Bio-Rad Laboratories, Her-
cules, CA). The proteins were resolved on a 10%
SDS-PAGEand then transferred topolyvinyl diflu-
oride membranes. Membranes were blocked with
Tris-buffered saline containing 0.1% Tween 20
(TTBS) containing 5% (wt/vol) BSA during 2 h at
25C. Primary antibodies included antiphosphory-
lated (p)-JAK2, p-Tyr705-STAT3, p-Thr308-Akt,
p-Ser473-Akt, anti-FOXO1, anti-pSer468-RelA,
IkB-, RelA, and anti-suppressor of cytokine sig-
naling 3 (SOCS3) from Cell Signaling Technology
(Danvers, MA); anti-JAK2, anti-protein tyrosine
phosphatase type 1B (PTP1B), and anti-p85 from
MilliporeCorp. (Billerica,MA); anti-Akt and anti-
IR from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA); anti-STAT3 fromR&DSystems (Min-
neapolis, MN); anti-phosphatase and tensin ho-
molog deleted on chromosome 10 (PTEN) and
anti-IRS-1 and -4 from Upstate Biotechnology
(Lake Placid, NY). All membranes were incubated
with the primary antibodies (diluted 1:1000) in
blocking buffer at 4 C overnight. The membranes
werewashed three timeswithTTBS and incubated
with the corresponding secondary antibody conju-
FIG. 1. Mean daily food (A) and water intake (B), body weight (C), energy expenditure
(D), locomotor activity (E), and rearing number (F) in WT D IRS2/ and ND IRS2/mice.
*, P  0.05; **, P  0.01; ***, P  0.001 by ANOVA.
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gated with peroxidase (Thermo Fisher Scientific, Inc., Waltham,
MA) at a dilution of 1:2000 in nonfat milk during 90min at 25 C.
The proteins were detected by chemiluminescence using an ECL
system (PerkinElmer Life Sciences, Boston,MA) and quantified by
densitometry using aKodakGelLogic 1500 ImageAnalysis system
and Molecular Imaging Software version 4.0 (Eastman Kodak,
Rochester, NY). All blots were reblottedwith anti-glyceraldehyde-
3-phosphate dehydrogenase (GAPDH; AnaSpec, San Jose, CA) to
normalize each sample for gel-loading variability.
Bead array assay
The phosphorylated form of c-Jun N-terminal kinase (JNK)
and total content were measured as previously described (29).
Beads with fluorescent-labeled antigen conjugated to the anti-
body and tissue lysates (50 l each) were incubated for 18 h at
roomtemperature.Wellswerewashed, andantibody conjugated
to biotin (25 l) was added. After 30 min, beads were incubated
during 30minwith 50l streptavidin conjugated to phycoeryth-
rin (streptavidin- phycoerythrin, diluted 1:100). Beads were an-
alyzed in a Bio-Plex suspension array system 200 (Bio-Rad Lab-
oratories, Hercules, CA). Raw data (mean fluorescence
intensity) were analyzed using the Bio-Plex Manager software
4.1 (Bio-Rad Laboratories).
RNA extraction, reverse transcription (RT), and
real-time PCR
TotalRNAwasextractedaccordingto theTri-Reagentprotocol
(Sigma, Saint Louis,MO).TheRT reactionwas performedon2g
of total RNA using the high-capacity cDNA archive kit (Applied
Biosystems, Foster City, CA). Real-time PCRwas performed in an
ABI Prism 7000 Sequence Detection System (Applied Biosystems)
usingTaqManPCRMasterMix(AppliedBiosystems)andthe ther-
mocycler parameters recommended by the manufacturer. PCR
were performed in duplicate, in a total volume of 50l, containing
12.5 l of the RT reaction. TaqMan gene expression assays were
used for ObRb (long form of the leptin receptor), IRS1, NPY, and
POMC (Mm00440181, Mm01278327, Mm00445771, and
Rn00595020, respectively; Applied Biosystems). Relative TNF-,
IL-1, IL-6,clusterofdifferentiation(CD)11c(CD11c),CD68,and
F4/80mRNAlevelsweremeasuredwithSYBRGreen (Roche), and
primerswere fromSigma. The forward and reverse sequenceswere
the following: 5-CATCTTCTCAAAATTCGAGTGA-3 and 5-
GGGAGTAGACAAGGTACAAC-3; 5-GCAACTGTTCCT-
GAACTCAACT and ATCTTTTGGGGTCCGTCAACT-3; 5-
TAGTCCTTCCTACCCCAATTTCCandTTGGTCCTTAGCC-
ACTCCTTC-3; 5-GCCCAGGGATATGTTCACAGC-3 and
5-ACACAGTGTGCTCCAGTATGA-3; 5-CAAGGTCCAG-
GGAGGTTGTG-3 and 5-CCAAAGGTAAGCTGTCCATA-
AGGA-3; and5-CTTTGGCTATGGGCTTCCAGTC-3 and5-
GCAAGGAGGACAGAGTTTATCGTG-3, respectively. The
PCRmixturecontains300nMofeachprimer.Relative
gene expression comparisons were carried out using
an invariant endogenous control (GAPDH). Accord-
ing to the manufacturer’s guidelines, the CT
method was used for relative quantification.
Immunohistochemistry
Double-fluorescent immunohistochemistry for
FOXO1 and NPY was carried out in free-floating
vibratome sections (30 m) in agitation. Sections
were washed with Dulbecco’s PBS 1  (Invitro-
gen, Auckland, New Zealand) and 0.1 M phos-
phate buffer (PB), pH 7.4, containing 0.3% BSA,
0.3% Triton X-100 (PBT) three times each. All
subsequent washes were carried out with PBT
three times. Sections were blocked for 90 min at
room temperature in PB with 0.3% Triton X-100
and 3% BSA and incubated o/n at 4 C with anti-
FOXO1 (1:250) and anti-NPY (1:100, Peninsula
Laboratories, San Carlos, CA) with blocking buf-
fer. Sections were then washed and incubated for
90 min at room temperature with antigoat IgG bi-
otin (1:1000) with blocking buffer. Afterward sec-
tions were washed and incubated under dark con-
ditions with streptavidin, Alexa Fluor 488 (1:1000,
Molecular Probes, Leiden, The Netherlands), and
Alexa Fluor 633 antirabbit IgG (1:1000, Molecular
Probes) in blocking buffer for 90 min at room tem-
perature and washed three times with PB. Sections
were mounted and cover slipped with Clear Mount
(ElectronicMicroscopy Sciences, Hatfield, PA). Im-
munofluorescence was visualized directly by using
a DM IRB confocal microscope (Leica, Wetzlar,
Germany).
FIG. 2. Serum glucose (A), triglycerides (TG) (B), NEFA (C), leptin (D), and insulin
concentrations (E) in WT D IRS2/ and ND IRS2/ mice. *, P  0.05; **, P  0.01;
***, P  0.001 by ANOVA.
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ELISA
Serum leptin and insulin levels were measured with ELISA
kits fromMillipore according to themanufacturer’s instructions.
The sensitivity was 0.04 ng/ml for leptin and 0.2 ng/ml for in-
sulin. The intra- and interassay variations for leptin were 2.3%
and 3.5%, respectively, and for insulin 1.9% and 7.6%,
respectively.
Colorimetric methods
Quantitative determinations of triglycerides and
nonesterified fatty acids (NEFA) in serum were per-
formedbyenzymaticcolorimetricmethodassays from
Randox(Ardmore,UK)andWako(Neuss,Germany),
respectively.
Statistical analysis
All results are presented as mean  SEM. Statis-
tical analysis of all data was carried out by one-way
ANOVA followed by aBonferroni’s test. The values
were considered significantly different when P 
0.05. Statistical analyses were performed using
Prisma software 4.0 (GraphPad, San Diego, CA).
Results
Food intake, body weight, and
metabolic studies
Food and water intake were increased in D
IRS2/ mice after the debut of diabetes, com-
pared withWT andND IRS2/mice (Fig. 1, A
and B, respectively). The body weight of ND
IRS2/ mice was slightly, but significantly,
higher than WT and D IRS2/mice at time of
death (Fig. 1C). Mean energy expenditure was
diminished inD IRS2/mice comparedwithWT(Fig. 1D).
The locomotoractivity (Fig.1E)andnumberof rearings (Fig.
1F) were decreased in both groups of IRS2/mice.
Plasma profiles differ in D and ND IRS2/ mice
Diabetic IRS2/mice had higher blood glucose levels
thanWTandND IRS2/mice. Blood glucose levelswere
also higher in ND IRS2/ mice compared
with WT, but significantly lower than D
IRS2/mice (Fig. 2A). Serum triglyceride lev-
elswere increased inDIRS2/mice compared
with WT and ND IRS2/ mice, (Fig. 2B),
whereas NEFA were augmented in ND
IRS2/ mice with respect to D IRS2/ mice
(Fig. 2C).
Serumleptin levelswerereduced inDIRS2/
mice and increased in ND IRS2/ mice (Fig.
2D), whereas insulin levels were increased in
both IRS2/ groups, with this increase being
greater in ND IRS2/mice (Fig. 2E).
Differential activation of leptin-related
signaling pathways in hypothalamus of
D and ND IRS2/ mice
The hypothalamic mRNA levels of ObRb
were not different between the experimental
groups (Fig. 3A). ND IRS2/ mice presented
higher levels of JAK2 (Fig. 3B) and STAT3
phosphorylation (Fig. 3C) than D IRS2/ or
FIG. 3. Leptin-related intracellular signaling components in the hypothalamus of
WT, D IRS2/, and ND IRS2/ mice. A, Relative levels of the mRNA for the ObRb.
Relative protein levels of phosphorylated (p) JAK2 (B), STAT3 phosphorylated on
tyrosine 705 (pTyr705-STAT3) (C), and SOCS3 (D). DU, Densitometry units; NS,
nonsignificant P  0.53; *, P  0.05 by ANOVA.
FIG. 4. Insulin receptor, IRS1, and activation of JNK in the hypothalamus of WT, D
IRS2/, and ND IRS2/ mice. A, Relative protein levels of the insulin receptor 
chain (IR). B, Relative IRS1 protein levels. C, Relative IRS1 mRNA content. D, Relative
phosphorylated (p) JNK protein levels. DU, Densitometry units; MFI, mean
fluorescence intensity; NS, nonsignificant P  0.68; *, P  0.05 by ANOVA.
Endocrinology, February 2012, 153(3):0000–0000 endo.endojournals.org 5
WT mice. However, levels of SOCS3 were lower in D
IRS2/ mice compared with both WT and ND IRS2/
mice (Fig. 3D).
Activation of the IRS1/PI3K pathway is higher in
the hypothalamus of ND IRS2/ compared with D
IRS2/ mice
ND IRS2/ mice had lower concentrations of insulin
receptor (IR) compared with WT mice (Fig. 4A). How-
ever, IRS1 levels were higher in ND IRS2/ mice (Fig.
4B). To test whether this increase was due to an increase
in protein synthesis and/or protein stability, mRNA levels
were measured. No differences in these levels were found
among the experimental groups (Fig. 4C). Because the ac-
tivationof JNKdecreases IRS1 stability promoting its deg-
radation (30), we measured the phosphorylation of JNK
as an index of its activation. Diabetic IRS2/mice had a
higher ratio of activation than WT and ND
IRS2/ mice, with no differences between
these groups (Fig. 4D). No changes in levels of
IRS4 were detected among the experimental
groups (WT, 100.0 14.3; D IRS2/, 92.7
21.8; andND IRS2/, 81.410.7, expressed
as percentage of densitometry units of WT).
PI3K is a point of convergence between the
leptin and insulin pathways, and the associa-
tion between JAK2 and IRS stimulates its ki-
nase activity (31). Accordingly, we studied the
association between JAK2 and IRS1. D
IRS2/ mice presented lower association be-
tween JAK2 and IRS1 whereas ND IRS2/
mice exhibited higher association than WT
mice (Fig. 5A). We then analyzed the associa-
tion of the regulatory subunit of PI3K (p85)
with IRS1. ND IRS2/mice had higher asso-
ciation of these proteins than WT and D
IRS2/ mice (Fig. 5B).
PTEN is known to be one of the major neg-
ative regulators of the PI3Kpathway (32). Lev-
els of this phosphatase were higher in D
IRS2/ mice (Fig. 5C). Both groups of
IRS2/mice had increased pAkt-Thr308 lev-
els (Fig. 5D), whereas pAkt-Ser473 was only
significantly increased in ND IRS2/ mice
(Fig. 5E).
PTP1B is a protein tyrosine phosphatase
that negatively regulates leptin signaling, as
well as insulin sensitivity, by directly interact-
ing with the insulin receptor (33). No differ-
ences in PTP1B levels were found among the
groups (WT, 100.0 6.0; D IRS2/, 98.5
21.1; and ND IRS2/, 97.4 5.6, expressed
as percentage of densitometry units of WT).
FOXO1 levels, cellular localization, and relative
NPY and POMC mRNA levels differ in D IRS2/
and ND IRS2/ mice
D IRS2/ mice had higher levels of FOXO1 than the
other groups (Fig. 6A). Immunohistochemistry showed
that FOXO1 is mainly expressed in the cell nuclei of D
IRS2/mice (Fig. 6C) in the arcuate nucleus, whereas it
ismostly located in the cytoplasmofWT (Fig. 6B) andND
IRS2/ mice (Fig. 6D).
FOXO1 differentially modulates the neuropeptides
regulating food intake, increasing the expression of orexi-
genic peptides and inhibiting anorexigenic factors (10).
Levels of NPY mRNA were increased in D IRS2/ mice
with respect to WT and ND IRS2/ mice (Fig. 6E),
whereas POMC mRNA levels were lower in D IRS2/
FIG. 5. Insulin-related intracellular signaling components in the hypothalamus of
WT, D IRS2/, and ND IRS2/ mice. Relative protein levels of JAK2 associated with
IRS-1 (A), relative levels of the regulatory subunit of PI3K (p85) associated with IRS1
(B), relative protein levels of PTEN (C), relative phosphorylated (p) Akt on threonine
308 (pThr308-Akt) protein levels (D), and relative pAkt on serine 473 (pSer473-Akt)
protein levels (E). For quantification, JAK2 or p85 associated with IRS1 was measured
by immunoprecipitation (IP) of 500 g of total protein with IRS1 antibody followed
by Western blot with anti-JAK2 or anti-p85 antibodies and normalized against
GAPDH levels in the same samples. DU, Densitometry units; *, P  0.05; **, P 
0.01 by ANOVA.
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mice compared withWT (Fig. 6F). Double immunohisto-
chemistry for FOXO1 in conjunction with NPY was per-
formed to analyze their coexpression. Figure 6, panels
G–O, illustrates that there is colocalization of NPY and
FOXO1 in the cytoplasm in WT (Fig. 6, G–I) and ND
IRS2/ mice (Fig. 6, M–O), whereas D IRS2/ mice
presented FOXO1 in the nucleus and NPY in the cyto-
plasm (Fig. 6, J–L).
Hypothalamic inflammation in D IRS2/ is higher
than in ND IRS2/ mice
Diabetic IRS2/ mice had higher hypothalamic
mRNA levels of TNF- than WT and ND IRS2/ mice
(Fig. 7A), and IL-6mRNA levelswere higher inD IRS2/
and ND IRS2/ mice compared with WT (Fig. 7B),
whereas no changes were detected in IL-1mRNA levels
(Fig. 7C). Total protein levels of IkB- were not different
between the experimental groups (Fig. 7D), and pSer468-
RelA was increased in D IRS2/ mice (Fig. 7E).
Real-time PCRofCD11c, CD68, and F4/80
revealed no significant differences in the
mRNA levels of CD11c (100.0 10.9, 96.6
17.2, and96.013.0, expressed as percentage
of control inWT,D IRS2/, andND IRS2/
mice, respectively), CD68 (100.0  13.7,
89.7  8.4, and 115.7  16.9, expressed as
percentage of control in WT, D IRS2/, and
ND IRS2/ mice, respectively) and F4/80
(100.0 17.1, 78.6 10.7, and 94.2 13.5,
in WT, D IRS2/, and ND IRS2/mice, re-
spectively) among the experimental groups.
Discussion
In this study, we found an up-regulation of hy-
pothalamic IRS1 togetherwith an increased in-
teraction between IRS1 and JAK2 that acti-
vates insulin signaling, which could be a
protecting factor against diabetes in ND
IRS2/ mice. The increase in both leptin and
insulin serum levels in ND IRS2/mice could
be responsible for the increased activation of
their central signaling mechanisms. Another
outstanding finding is theabsenceof changes in
NPY and POMC in this group, probably re-
lated not only to FOXO1 levels but to its cy-
tosolic location as well, which was similar to
that of WT mice. In addition, the absence of a
compensatory increase of IRS1 levels in D
IRS2/mice, together with a lower leptin sig-
naling compared with ND IRS2/ mice, re-
duces the inhibitory effect of both signaling
pathways on FOXO1-mediated transcription, allowing
an orexigenic pattern of neuropeptide expression, concor-
dant with hyperphagia in diabetic mice.
The increased food intake in D IRS2/ mice is con-
sistent with previous reports (11). Despite increased insu-
lin levels, diabeticmice have low leptin levels, which could
account for the increase in food intake (34). This increased
food intake is in accordance with the changes in NPY and
POMCobserved here. Both leptin and insulin regulate the
hypothalamic neuropeptides that control food intake
(35), and the signaling pathways of these two hormones
are interconnected at different levels, such as IRSandPI3K
(36). Activation of PI3K in peripheral tissues by leptin has
been reported to be dependent on IRS1 association with
JAK2and the85-kDa subunit of PI3K (37).Herewe found
increased activation of JAK2, as well as higher associa-
tions of JAK2-IRS1 and p85-IRS1 in ND IRS2/ com-
pared with D IRS2/ mice. Higher serum insulin con-
FIG. 6. Levels and localization of FOXO1, NPY, and POMC mRNA content in the
hypothalamus and double immunohistochemistry for FOXO1 and NPY in the arcuate
nucleus of WT, D IRS2/, and ND IRS2/ mice. A, Relative protein levels of FOXO1.
B–D, Immunohistochemistry of FOXO1 (green) in the hypothalamus of the three
experimental groups. Note the cytoplasmatic localization of FOXO in WT and ND
IRS2/ mice and nuclear localization in D IRS2/ mice. Scale bar, 25 m; inset, 40
m. E, Relative NPY mRNA content. F, Relative POMC mRNA content. G–O, Double
immunohistochemistry for FOXO1 (green) and NPY (red) in the arcuate nucleus.
FOXO1 (G) and NPY (H) in WT mice. Note the colocalization in the merged image (I),
FOXO1 (J), and NPY (K) in D IRS2/ mice. Note the colocalization in the merged
image (L), FOXO1 (M), and NPY (N) in ND IRS2/ mice. Note the colocalization in
the merged image (O). Scale bar, 40 m. DU, Densitometry units; *, P  0.05 by
ANOVA.
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centrations and hypothalamic IRS1 levels in ND IRS2/
mice compared with WT and D IRS2/ mice are most
likely responsible for activation of the insulin signaling
pathway, because IRS4 levels did not change. This in-
creaseappears tobedue toan increase in IRS1stability and
not to new synthesis, because IRS1 mRNA levels did not
change. Activation of the JNK pathway interferes with
insulin action by increasing IRS1 phosphorylation at serine
307 (38). This phosphorylation not only inhibits its interac-
tionwith the insulin receptor,but increases itsdegradationas
well (39). Therefore, higher JNK activation in D IRS2/
mice might explain the lack of compensatory up-regula-
tion of IRS1 levels in these animals.
We also found an increase in PTEN levels in D IRS2/
mice. This phosphatase inhibits the PI3K pathway by an-
tagonizing this kinase (36), and it may play a role in dia-
betes as a negative regulator of insulin signaling. There is
evidence demonstrating that animals have increased insu-
lin sensitivity when PTEN is deleted (40) and that patients
with mutations consisting in the loss of PTEN function
have enhanced insulin sensitivity (41). Thus, an increase in
PTEN levels may explain the lower phosphorylation of
Akt on Ser473 in diabetic mice with respect to
ND mice. However, the increase in Akt phos-
phorylation in Thr308 in ND and D IRS2/
mice may be related to glucose levels, because
this phosphorylation is regulated by glycemia
(42), and both groups were hyperglycemic
compared with WT mice.
The pivotal role of increased IRS1 in ND
IRS2/ mice may lead to higher Akt phos-
phorylation and lower nuclear FOXO1 than in
D IRS2/mice. After Akt activation, FOXO1
is phosphorylated, exiting the nucleus (43)
and, once in the cytoplasm, it is degraded by an
ubiquitin proteasome-mediated system (44).
Normal levels of FOXO1 and its cytoplasmic
localization inND IRS2/mice, aswell as the
inverse pattern found in both levels and localiza-
tion in D IRS2/ mice, correlate with the sig-
naling of leptin and insulin and with the expres-
sion of hypothalamic neuropeptides involved in
the regulationof food intake. Interestingly, it has
been reported that phosphorylation of cytoplas-
mic FOXO1 at specific sites by JNK initiates the
translocation into the nucleus (45). Thus, the
higher activation of JNK in D IRS2/ mice
could also contribute to FOXO1 nuclear local-
ization. D IRS2/ mice presented hyperphagia
and an orexigenic pattern of these neuropep-
tides that may be related with an altered sig-
naling of leptin and insulin, as previously re-
ported both in humans and animal models of resistance to
both hormones (46, 47). In fact, animals with defective
PI3K pathways or with a FOXO1 mutation resulting in
constitutively nuclear location, show increased food in-
take and body weight accompanied by decreased expres-
sion of the POMC gene in the hypothalamus (48). On the
contrary, inhibition of hypothalamic FOXO1 increases
insulin sensitivity and reduces cumulative food intake
(49). In turn, the activationof FOXO1stimulates the tran-
scription of NPY and increases food intake (50), as we
report in D IRS2/ mice. Despite higher Akt phosphor-
ylation in ND IRS2/ mice, which has been shown to
increase FOXO1 exportation to the cytoplasm and in-
crease its degradation (51), the levels of FOXO1 found
were similar to controls. It must be remembered that
FOXO1 levels are regulated not only by phosphorylation,
but also by other posttranslational modifications such as
ubiquitination and acetylation that might change the sta-
bility of this factor (52).
IRS1-related signaling may confer resistance against
hypothalamic inflammation in ND IRS2/ mice. There
was an increase in RelA phosphorylation at Ser-468 and
FIG. 7. Hypothalamic proinflammatory expression markers, levels of IkB, and
activation of RelA in the hypothalamus of WT, D IRS2/, and ND IRS2/ mice. A,
Relative levels of the mRNA for TNF- (A), IL-6 (B), and IL-1 (C). Relative protein
levels of IkB- (D) and phosphorylated (p) RelA on serine 468 (pSer468RelA) (E). DU,
Densitometry units; NS, non significant P  0.21; *, P  0.05; **, P  0.01 by
ANOVA.
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TNF- mRNA levels in D IRS2/ mice. Usually, under
basal conditions, hypothalamic NFB activity is inactive
or modestly activated (19), but its activation in peripheral
tissues has been described in diabetic patients (53). It has
been shown that phosphorylation of RelA at Ser-468 is
mainly located in thenucleus (54) and is required to induce
the expression of several proinflammatory NFB-depen-
dent genes (55). Our data suggest a possible link between
IRS1/PI3K/Akt and the reduction of antiinflammatory ef-
fects inND IRS2/mice.We have previously shown that
activation of Akt inactivates glycogen
synthasekinase-3byphosphorylation
at Ser-9 (56), and it is known that gly-
cogen synthase kinase-3 is involved in
the regulation of NFB activation and
inflammatory response (57). There-
fore, IRS1-mediated activation of Akt
may reduce hypothalamic inflamma-
tion in these mice. In line with this, pre-
vious reports have shown that antiinflam-
matory and insulin-sensitizing drugs
increase pAkt levels (26, 27).
TNF- exerts different actions in the
pathogenesis of diabetes, and several
functions related to the control of en-
ergy expenditure depend on its actions
in the hypothalamus. In fact, this factor
acts by producing a proinflammatory
response through the inductionofother
cytokines and changing the expression
of neurotransmitters implicated in the
control of feeding (58). Intriguingly, D
and ND IRS2/ mice present similar
increases in IL-6 mRNA levels. The in-
crease in D IRS2/ mice may be in-
duced by TNF- (58), whereas in ND
IRS2/ mice it could be due to in-
creased pSTAT3 levels, as activated
STAT directly binds to the IL-6 pro-
moter, increasing its transcription (59).
In both D and ND IRS2/mice IL-1
andCD11c,CD68, andF4/80,markers
of activated microglia, did not differ
from theWT group; thus there is only a
low grade of hypothalamic inflamma-
tion at most. Considering that in the
ND IRS2/ mice only IL-6 was al-
tered, and this cytokine can be either
proinflammatory or antiinflammatory,
the inflammation state in these animals
is not clear.
Experimentally induced inflamma-
tion in the hypothalamus reduces oxygen consumption
(23), which is concordant with data presented here, be-
cause energy expenditure is reduced inD IRS2/mice. In
these animals there was an increase in hypothalamic
mRNA levels of TNF-, and it has been shown that this
cytokine exerts a central anabolic effect at low concentra-
tions, inhibiting the actions of leptin and insulin (60). Lo-
comotor activity and the number of rearings are reduced
in both IRS2/mice groups. This fact could be related to
the neurological alterations described in these knockout
FIG. 8. A model of differential modulation of neuropeptides regulating food intake by leptin
and insulin signaling in the hypothalamus of D IRS2/ and ND IRS2/ mice. Leptin binds to
ObRb and activates JAK2 and STAT3, which, in turn, may activate the expression of POMC
gene. Leptin also increases the association of IRS1 with JAK2, which promotes activation of
the PI3K pathway by increasing the association of IRS1 with the p85-regulatory subunit of
PI3K. The increase in the activity of PI3K and the reduction of PTEN levels results in Akt
activation, inducing the translocation of FOXO1 to the cytoplasm where it is then degraded,
decreasing their total levels in the hypothalamus. FOXO1 acts on expression of neuropeptides
regulating food intake, resulting in an increase of food intake in D IRS2/ mice. Leptin
signaling through STAT3 activation may increase POMC levels, whereas FOXO1 may bind to
nuclear STAT3, inhibiting this stimulatory effect. Activation of Akt may also reduce the
inflammation in ND IRS2/ mice. Activation (or increase) and inhibition (or reduction) in D
IRS2/ mice (black arrow) or ND IRS2/ mice (gray arrow) is indicated. Absence of arrows
indicates the inexistence of differences with respect to WT mice. Length of the arrow shows
relative degree of activation or inhibition. AMPK, AMP-activated kinase; IR, insulin receptor;
p110, catalytic subunit of PI3K; Solid lines represent pathways studied here. and dashed
arrows symbolize previously published pathways.
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mice (61) and also with the role of IRS2 activation that is
suggested to account for the increase in PI3K activity after
exercise in controls (62).
Our results indicate that bodyweightmay contribute to
the differential signaling in D and ND IRS2/ mice. D
IRS2/mice present lower bodyweight that is associated
with decreased leptin levels and signaling in these mice,
whereas the higher weight of ND IRS2/mice is related
to increased leptin and insulin levels and possibly the
IRS1-associated effects. The contribution of themetabolic
context cannotbe excludedbecausewe foundhigher levels
of triglycerides in D IRS2/, mice and it has been shown
that insulin resistance is also predicted by serum triglyc-
eride concentrations (63).
Development of diabetes in IRS2/micehas been clas-
sically related to decreased -cell function combined with
blunted insulin signaling in the liver (17), although the
hypothalamus could be also involved in the onset of the
disease.On the one hand, the delay in the onset of diabetes
could be due to the hyperinsulinemia inND IRS2/mice
by a compensatory effect of -cell, and on the other hand,
increased hypothalamic IRS1 signaling could exert a pro-
tective rolebyactivatingAkt,which reduceshypothalamic
inflammation, as discussed above (26, 27). The hypotha-
lamic inflammation reproduces some clinical features of
type 2 diabetes and impairs pancreatic islet function (24)
and hepatic insulin signaling (25). Alternatively, it is pos-
sible that the primary event in D IRS2/mice is the onset
of severe diabetes that may lead to fat mass loss with a
subsequent reduction of leptin levels and associated hy-
perphagia. In fact, replacement of leptin concentrations
reestablishes adequate food intake and prevents insulin
resistance induced by uncontrolled diabetes (64, 65);
our results could indicate that the changes in leptin and
insulin levels and IRS1-mediated signaling result in dif-
ferential hypothalamic control of food intake in the two
IRS2/ groups, suggesting again a protecting hypotha-
lamic role against the development of diabetes in ND
IRS2/ mice. Thus, the use of diets (14) or pharmaco-
logical inhibition of specific targets in IRS2/ mice to
improve IRS1-mediated insulin signaling (66) may lead to
new strategies for diabetes in the future.
A couple of caveats should be considered when evalu-
ating these results. The hypothalamus is composed of di-
verse cell populations, and we have performed a semi-
quantitative study of the entire hypothalamus for most of
the analyzed parameters. Indeed, it is probable that dis-
tinct mechanisms are occurring in different cell types. The
mechanism is complex as it implies not onlymodulationof
neuropeptide expression through FOXO1 regulation and
the modulation of hypothalamic fatty acid synthesis, but
also IRS1 compensatory mechanisms that may be occur-
ring in some, but not all, cells. However, the differences
in the overall modifications in leptin and insulin signal-
ing in the hypothalamus of D and ND IRS2/ mice
highlight the importance of this mechanism in deter-
mining the differential changes in metabolic neuropep-
tide expression and food intake. We also must consider
that the similar signaling for leptin and insulin inWT and
ND IRS2/ mice does not entail an equal hypothalamic
response to these hormones in NDmice. Thus, our results
indicate that the higher weight and serum NEFA concen-
trations inND IRS2/mice could increase hypothalamic
resistance to leptin and insulin.
In conclusion, as summarized in Fig. 8, our data suggest
that a compensatory increase of IRS1 and the activation of
leptin- and insulin-signaling pathways in the hypothala-
musmayexert aprotective effect against thehypothalamic
defects inducing inflammation that lead to deregulation in
the control of appetite and metabolism. These findings
contribute to our understanding of the mechanisms in-
volved in the pathogenesis of these disorders and seem to
indicate that the manipulation of targets for both hor-
mones in the hypothalamus could be promising for the
treatment of insulin resistance and diabetes.
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